Afuco™ Anti-IL13 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-219)

CAT#: AFC-TAB-219

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL13. It is a humanized monoclonal antibody and an experimental immunosuppresive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids.

Gene Expression
Figure 1 IF staining of human cell line U-2 OS Figure 2 IF staining of human cell line A-431 Figure 3 IF staining of human cell line U-251 MG Figure 4 RNA cell line category: Cell line enriched (HDLM-2)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • ELISA, Neut, IF, IP, FC, FuncS
  • Conjugate
  • Unconjugated
  • Trade name
  • Tnx-650
  • Generic Name
  • Lebrikizumab
  • Related Disease
  • Idiopathic pulmonary fibrosis

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IL13; interleukin 13; interleukin-13; allergic rhinitis; ALRH; BHR1; Bronchial hyperresponsiveness 1 (bronchial asthma); IL 13;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-219. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Lebrikizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Lebrikizumab.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Lebrikizumab"

DrugMonitor™ Anti-Lebrikizumab Antibody (VS-1224-YC647)
Lebrikizumab is a monoclonal antibody binding IL-13 with high affinity and slow off-rate, approved for treating moderate-to-severe atopic dermatitis. The DrugMonitor™ Anti-Lebrikizumab Antibody (VS-1224-YC647) is an anti-drug antibody (ADA) against Lebrikizumab. This drug-based antibody is raised in mice immunized with the Lebrikizumab. The anti-Lebrikizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Lebrikizumab in samples.

See other products for "IL13"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-094ZJ Anti-Human IL-13 Recombinant Antibody (167) ELISA Chimeric antibody (mouse/human)
TAB-094ZJ-S(P) Anti-Human IL-13 Recombinant Antibody scFv Fragment (167) ELISA Chimeric antibody (mouse/human)
TAB-094ZJ-F(E) Anti-Human IL-13 Recombinant Antibody Fab Fragment (167) ELISA Chimeric antibody (mouse/human)
CAT Product Name Application Type
AFC-TAB-H05 Afuco™ Anti-IL13 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H05) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-017ML Afuco™ Anti-IL13 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-017ML) ELISA, IHC, FC, IP, IF, Inhib ADCC enhanced antibody
AFC-TAB-218 Afuco™ Anti-IL13 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-218) ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody
CAT Product Name Application Type
VS-0225-XY129 CytoStream™ Rat Anti-IL13 Recombinant Antibody (clone JES10-5A2) ELISA, FC, Neut, IHC, WB Rat IgG1
CAT Product Name Application Type
VS-0425-FY124 Human Anti-IL13 (clone IMA-638) scFv-Fc Chimera ELISA, FC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0525-XY3484 Anti-IL13 Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare